Karyopharm Therapeutics Inc. (KPTI) › Total AssetsKaryopharm Therapeutics Inc. (KPTI) — Total AssetsAnnual figures by fiscal year, from SEC filings.2012: $1.31M2013: $158.23M2014: $220.34M2015: $215.44M2016: $180.38M2017: $180.29M2018: $341.19M2019: $294.96M2020: $313.05M2021: $305.31M2022: $358.17M2023: $240.44M2024: $164.42M2025: $108.42M$108.42M2012Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$108.42M-34.1%2024$164.42M-31.6%2023$240.44M-32.9%2022$358.17M+17.3%2021$305.31M-2.5%2020$313.05M+6.1%2019$294.96M-13.5%2018$341.19M+89.2%2017$180.29M-0.1%2016$180.38M-16.3%2015$215.44M-2.2%2014$220.34M+39.3%2013$158.23M+11969.1%2012$1.31M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share